Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000432 · ClinicalTrials.gov registry record · Phase 3
Lyme Disease Prevention Program
A Phase 3 study of Lyme Disease and Tick-borne Diseases, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 20,000
- Enrollment target
- 1
- Study location
NCT00000432 is a Phase 3 study of Lyme Disease and Tick-borne Diseases that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 20,000 participants, above the 1,652-participant average among 9 other Lyme Disease trials with a reported enrollment target (1111% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00000432, a Phase 3 study of Lyme Disease and Tick-borne Diseases, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a large study of an educational program on Lyme disease prevention for passengers on ferry boats going to Nantucket Island during the period from Memorial Day until Labor Day. Some boats provide passengers with the experimental program and the other boats provide a "control" program that the researchers can compare to the experimental program. The experimental program uses live performances by entertainers to teach people about Lyme disease prevention, and also uses additional printed materials. People on the control boats receive education on injury prevention and road safety while bicycling, rollerblading, and using mopeds. The main result we will look for is Lyme disease identified by a followup survey and confirmed by reviewing medical records. We will also ask some people to take part in a smaller study of behavior change. In this study, we will ask people to complete forms on self-efficacy (a person's belief in his or her ability to reach a certain goal), their plans to take preventive steps, and actual prevention behaviors. We also ask participants who report doctor visits or illness to provide confirmation of their use of health services.
Conditions Studied
Interventions
- BEHAVIORAL Education about disease prevention
Study Locations (1)
Massachusetts
- Steamship Authority ferry boats to Nantucket Island - Hyannis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 1997-04 |
| Est. Completion | 2001-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000432
The ClinicalTrials.gov registry entry for NCT00000432 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 20,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,652-participant average among 9 other Lyme Disease trials with a reported enrollment target (1111% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lyme Disease appearing as the primary indexed condition, and to 1 intervention - of which Education about disease prevention is the first listed.
NCT00000432 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00000432 about?
NCT00000432 is a clinical study titled "Lyme Disease Prevention Program". This is a large study of an educational program on Lyme disease prevention for passengers on ferry boats going to Nantucket Island during the period from Memorial Day until Labor Day. Some boats provide passengers with the experimental program and the other boats provide a "control" program that the...
What is the current status of trial NCT00000432?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20,000 participants. The study started on 1997-04. Estimated completion is 2001-03.
What conditions does trial NCT00000432 study?
This clinical trial studies the following conditions: Lyme Disease, Tick-borne Diseases.
What interventions are being tested in trial NCT00000432?
The interventions under investigation include: Education about disease prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000432?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000432 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lyme Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)
ACTIVE NOT RECRUITING · Phase 3
-
Study and Treatment of Post Lyme Disease (STOP-LD)
COMPLETED · Phase 3
-
Human Immune Response to Ixodes Scapularis Tick Bites
RECRUITING · Phase 1
-
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure
RECRUITING
-
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
RECRUITING
-
Navigating Pregnancy and Parenthood With Lyme Disease
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.